This compound is an active pharmaceutical ingredient reference standard, structurally characterized as a quinoline derivative with a dihydroxyheptenoic acid side chain and a cyclopropyl group. It is provided for analytical and quality control applications in pharmaceutical manufacturing.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 1159631-31-8
(9Z,11E,13S)-13-hydroxyoctadeca-9,11-dienoic acid
active pharmaceutical ingredient reference standard
Icomucret
active pharmaceutical ingredient reference standard
Carboxy-nifedipine
active pharmaceutical ingredient reference standard
Cinacalcet Related Compound C
active pharmaceutical ingredient reference standard
(2S,3R,4S,5S,6R)-2-[(2R,3S,4R,5R)-6-[(3,5-Dimethyl-1-adamantyl)amino]-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
pharmaceutical intermediate or impurity
All-trans-Retinal
Vitamin A aldehyde metabolite
Pevonedistat Hydrochloride
NAE inhibitor antineoplastic agent
Insulin-aspart
active pharmaceutical ingredient
(Z,3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoic acid
VGYFMXBACGZSIL-DBBWNDPISA-N
C1CC1C2=NC3=CC=CC=C3C(=C2/C=C\[C@H](C[C@H](CC(=O)O)O)O)C4=CC=C(C=C4)F